Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Virtue Diagnostics
company
About
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $100M
- Industries
- Health Care,Health Diagnostics,Medical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$130M
Virtue Diagnostics has raised a total of
$130M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2022 | Series B | $100M | 1 | — | — | Detail |
| Dec 21, 2020 | Series A | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Virtue Diagnostics is funded by 1 investors.
Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lilly Asia Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
